Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
Age
6–12
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subject was randomized into Base Study (M06-888 or M10-345) and completed the Treatment Period.
If female, subject must be practicing at least one method of birth control throughout the study.
If female, the result of a pregnancy test is negative.
The subject is judged to be in generally good health.
You may not be if
The subject experienced a serious adverse event in Base Study (M06-888 or M10-345) that the investigator considered "possibly" or "probably related" to study drug.
The subject has taken any ADHD medication between the last dose of study drug in Study M06-888 or M10-345 and the first dose of study drug in the current study.
The subject has a positive urine drug screen for alcohol or drugs of abuse.
The subject anticipates a move outside the geographic area.
Clareo Health | A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
